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Abstract
Background: Chronic refractory hypotension (IDH, intradialytic hypotension) is a rare but serious problem encountered
in patients on hemodialysis. Patients with chronic hypotension are often disqualified by transplant teams from
renal transplantation. This is due to the possibility of an enormous risk of ischemic complications.
Case presentation: We describe a 44-year old female patient with severe refractory hypotension (mean BP 60/
30 mmHg, the lowest 48/28 mmHg), which appeared after bilateral laparoscopic nephrectomy of the infected
kidneys. The kidney transplantation from a deceased donor, with infusion of the two pressor amines (dopamine,
dobutamine) was performed without technical complications and the blood pressure measurements were
100–120/70–80 mmHg. The immunosuppression regimen was tacrolimus (TAC) + mycophenolate mophetil
(MMF) and steroids (GS). Pressor amines were discontinued on the 18th day after the transplantation. Because of delayed
graft function, 4 hemodialysis treatments were performed. The patient was discharged from the hospital on the 22nd day
with good function of the transplanted kidney (the concentration of serum creatinine 117 μmol/l). During
one-year follow-up, the patient has been remaining stable with a very good graft function (serum creatinine
84 μmol/l) and normal blood pressure (115/70 mmHg).
Conclusions: Proper preparation and adequate perioperative treatment allowed for safely performing kidney
transplantation in the patient with severe IDH.
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Background
Dialysis hypotension (IDH, intradialytic hypotension) is
a frequent complication in patients undergoing chronic
hemodialysis (HD). It is estimated that it affects approxi-
mately 10–70% of patients. Significant differences in the
incidence are associated with various definitions of this
disease. KDOQI (The National Kidney Foundation’s Kidney
Disease Outcomes Quality Initiative) defines IDH as a
decrease in systolic blood pressure > 20 mmHg or a de-
crease in mean arterial blood pressure (BP) of > 10 mmHg
with associated clinical symptoms (abdominal discomfort,
nausea, vomiting, fainting, dizziness, muscle cramps, etc.).
According to the KDOQI definition, IDH applies to ap-
proximately 20–30% of dialysis session [1].
IDH may occur as a form of acute (episodic), recurrent
(for a minimum of 50% of the dialysis session) or rarely
chronic dialysis hypotension, which is associated with
the occurrence of BP <100 mmHg between HD sessions
in 5–10% of patients. IDH is more common in elderly
patients with cardiovascular disease, on long-term dialysis,
in patients with diabetes, low levels of albumin, a high
body mass index (BMI) in women, as well as in patients
with low blood pressure before dialysis. The clinical conse-
quences of IDH include primarily a deterioration in the
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quality of life and increased mortality due to cardiovascular
complications. The effects of IDH are also associated with
a lack of obtaining adequate dialysis, which is associated
with the shortening of the dialysis session. The problems
involve a vascular accesses - frequent clotting of arterio-
venous fistulas [2, 3].
The occurrence of IDH is related primarily to the lack
of an adequate volume of circulating blood during the
dialysis session, which on the one hand results from in-
sufficient refilling plasma, and the other – an impaired
hemodynamic response from the myocardium and blood
vessels.
Factors affecting the presence of IDH are dependent
on the patient: being on antihypertensive medications,
the presence of cardiovascular diseases, a considerable
weight gain between dialyses, as well as on the manner
of HD application (the concentration of sodium, calcium,
the osmolarity of the dialyzate, the temperature of the dia-
lysis liquid and the type of buffer used in dialysis), and on
additional factors, such as anemia, hypoxia or intercurrent
infections.
To date, the pathophysiology of IDH has not been
completely understood. On the one hand, it is suggested
that a reduced response of the cardiovascular system to
vasopressor agents is associated with the occurrence of a
reduced response to stimuli from the adrenergic receptors -
there are indeed elevated levels of norepinephrine, but
with a reduced density of alpha2 adrenergic receptors.
In addition, there is a reduced response of alpha1 adrener-
gic receptors. Long-term dialysis treatment is also associ-
ated with an impaired baroreceptor function. Also reduced
density and a response from the beta1 and beta2 adrenergic
receptors have a clinical value. Another factor associated
with the occurrence of IDH is an increased production of
vasodilators (adrenomedullins and nitric oxide) as a result
of an increased production of proinflammatory cytokines.
Repeated episodes of organ hypoperfusion, the effect of
IDH, are associated on the one hand with hypertrophy and
myocardial fibrosis, and on the other - with an increase in
the level of endotoxins, which in turn leads to an increased
production of proinflammatory cytokines, oxidative stress
and dysfunction of endothelial cells [2, 4]. Another cause of
IDH may be bilateral nephrectomy leading to removal of
sympathetic stimulus from native kidneys [5].
The occurrence of chronic IDH usually leads to dis-
qualification of a patients from the kidney transplantation
procedure. To date, there are few reports in the literature
of a successful kidney transplantation with an improved
BP control in patients with chronic IDH.
Case presentation
A 44-year-old female patient with severe intradialytic
hypotension, (the mean BP were 60/30 mmHg, the lowest
BP 48/28 mmHg) was qualified for renal transplantation
by a team from the Department of Nephrology, University
Hospital after an in-depth diagnostic management.
The cause of the patient’s end-stage renal failure was
rapidly progressive glomerulonephritis with anti-GBM
treated in the past by plasmapheresis and Solu-Medrol
pulses. In addition, since the age of 20 years, she had bilat-
eral nephrolithiasis with recurrent urinary tract infections
and hypertension. The patient was on hemodialysis for
three years. One year after the commencement of dialysis,
the patient underwent bilateral laparoscopic nephrectomy
due to bilateral nephrolithiasis and recurrent urinary tract
infections - which are an obstacle in qualifying patient for
renal transplantation. Since that time, the patient has been
severely hypotensive. She denied fainting, reported a signifi-
cant weakness. In the course of hypotension, ischemic
neuropathy with loss of vision in the right eye occurred. In
addition, eye pain worsened during dialysis. Collaboration
with the patient while renal replacement therapy was car-
ried out was good, and her weight gain between dialysis
sessions did not exceed 2000 ml. HD sessions were carried
out in accordance with the standards for the IDH (the low-
ered temperature of the dialysis fluid, profiled sodium con-
centration, short-term infusion of colloids with declined
BP). Additionally, the adrenal CT (computed tomography)
scan was normal, as well as cortisol and ACTH (adrenocor-
ticotropic hormone) levels. Histological examination of the
rectal mucosa sample excluded amyloidosis. The results of
cardiac studies (echocardiogram and electrocardiography)
were also normal. The orthostatic stress test and Ewing’s
battery tests showed no abnormalities of the autonomic
nervous system, the heart rate variability was normal during
the all the tests. Treatment with mineralocorticoids and
midodrin did not result in the improvement of BP, but after
the dopamine infusion, her blood pressure increased to
satisfactory values (120/60 mmHg). The results of most
relevant laboratory and diagnostic tests performed in
patient are showed in Table 1. The patient was referred
for renal transplantation and placed on the waiting list. The
waiting time for kidney transplantation was 6 months.
The kidney for transplantation was harvested from a
deceased donor (33 years old male with overweight, after
intracranial injury, without arterial hypertension and
other diseases). The number of non-conforming HLA 2
A, 1 B and 1 DR, PRA max and the last was 0. The total
time of ischemia was 22 h, and warm ischemia - 50 min.
The patient used the following immunosuppression regi-
men: TAC + MMF + GS. Immediately prior to the trans-
plantation procedure, her BP was 60/40 mmHg. Before the
surgery, dopamine infusion at a dose of 5.3–7.4 μg/kg/min
resulted in an increase of BP to 100–120 mmHg. The
kidney transplantation procedure was performed without
complications. In the second day after surgery, the patient
was transferred to the Department of Nephrology. Due to
the low value of BP < 100 mmHg, dopamine infusion and
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additionally dobutamine infusion at a dose of 2.4–
3.6 μg/kg/min was ordered (Figs. 1 and 2). Initially,
heart rate value was in range between 100 and 120 per
minute, and during the reduction of aminopressor doses it
decreased to normal values (80/min.). A delayed function
of the transplanted kidney was observed, so 4 HD sessions
were performed. During the post-operative period, the
dosage of pressor amines was gradually reduced and
stopped 18 days after transplantation. The patient was dis-
charged from the hospital on day 22nd after transplant-
ation in a good condition, with BP of 105/60 mmHg, the
level of serum creatinine 117 μmol/L and eGFR 46 ml/
min. One year after transplantation procedure, the graft
function is stable, with the level of serum creatinine of
80 μmol/l and eGFR >60 ml/min, BP values are approx.
105–120/60–70 mmHg (Fig. 3). The patient was well re-
habilitated and returned to work.
Discussion
In the described case, before qualification for renal trans-
plantation, we excluded causes of IDH associated with
diseases of the cardiovascular system, as well as causes of
endocrine and autonomic nervous system dysfunction.
Young age and lack of comorbidities also spoke in favor of
the patient. Dialysis time before the kidney transplantation
spanned 3 years. Undoubtedly, a factor that had an impact
on the occurrence of hypotension in our patient was the
performance of bilateral nephrectomy as preparation for
renal transplantation. Double-sided nephrectomy or
percutaneous ablation of renal sympathetic nerve are
associated with a reduction in hyperactivity of the sympa-
thetic system [5]. This has important clinical signifi-
cance in patients with hypertension, particularly refractory
and poorly controlled. An improvement in BP control and
reduction in the number of antihypertensive medications
after bilateral nephrectomy have been reported [6]. There
are also reports of reduction in left ventricular mass and its
diastolic dysfunction in the group of such patients [7]. In
our patient, before bilateral laparoscopic nephrectomy, the
BP values were normal. Reducing the activity of the sympa-
thetic nervous system associated with the procedure, could
therefore contribute to the onset of hypotension. In
patients with chronic kidney disease (CKD) and patients
on dialysis, an increased activation of the sympathetic
nervous system, increased renin secretion, and increased
activity of the renin-angiotensin-aldosterone system after
bilateral nephrectomy were observed. Also this mechan-
ism of BP control in our patient has been weakened. Un-
fortunately, due to the lack of opportunities, we did not
determine in our patient the blood levels of adrenaline,
noradrenaline, renin and aldosterone during the period of
eligibility for transplantation.
Short-term dialysis (several months) prior to the IDH,
the lack of co-morbidities, such as diabetes, autonomic
neuropathy, and the correct state of the cardiovascular
system (echocardiography, electrocardiography) indicate
a good hemodynamic response from the myocardium
and peripheral vasculature in our patient.
Rogan et al., reported the beneficial effects of exercise
(stationary cycling without load during the dialysis session)
on BP in a patient with IDH after bilateral nephrectomy.
The exercise, performed during dialysis for 8 weeks
after renal transplantation, contributed to carrying out a
successful kidney transplant. The stimulation of chemo-
and mechanoreceptors during exercise improve BP con-
trol [8]. Our patient was also instructed as to the need to
perform resistance exercises, but such exercises did not
produce any major clinical effect in improving BP.
In some cases, the beneficial effect of IDH results from
the use of alpha 1-adrenergic receptor agonist - midodrin.
In our patient, we did not observe any beneficial effect of
the use of this drug.
The correct answer to the test use of the pressor
amines (dopamine) before surgery allowed for qualifying
the patient for renal transplantation.
Kim et al. describe a case of kidney transplantation in a
2-year-old child with dialysis hypotension and autonomic
Table 1 Results of most relevant laboratory and diagnostic tests
Type and name
of diagnostic test
Result/Value Normal
laboratory
range
Thyroid stimulating hormone 1.960 0.27–4.2
(TSH) [μIU/ml]
Triiodothyronine (FT3) [pmol/l] 3.4 3.1–6.8
Cortizol [μg/dl] 11.7 2.3–19.4
Adrenocorticotropic hormone 26.3 8.0–58.0
(ACTH) [pg/ml]
Hemoglobin (Hgb) [g/dl] 9.4 11.0–15.0
Total Cholesterol (TC) [mmol/l] 4.1 3.2–5.2
Sodium (Na) [mmol/l] 138 136–145
Echocardiography Ejection Fraction
70%, mitral and
tricuspid trace
regurgitation
not
applicable
Abdomen and Adrenal
tomography
No pathologies
within the abdomen
and adrenal
not
applicable
Ewing Battery tests No abnormalities
of the autonomic
nervous system
not
applicable
ECG and ECG stress test Correct results not
applicable
Consultations:
Neurological No contraindications
to kidney transplantation.
No exact cause from
intradialytic hypotension.
not
applicable
Cardiac
Endocrine
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neuropathy, which received a transplant from an adult de-
ceased donor. To obtain adequate perfusion of the trans-
planted kidney, the authors tried to achieve a value of
systolic BP approx. 100 mmHg during the perioperative
period. Due to the ineffective use of dopamine infusion
for this purpose, the authors successfully employed an
alpha agonist (neosinefrine) for a short time, despite the
risk of ischemia development and the risk of thrombosis
[9]. In the case of our patient, dopamine infusions for a
short period of time in conjunction with dobutamine were
effective. We also observed a clear correlation between
the possibility of diminishing the doses of pressor amines
and improvement of the function of transplanted kidney.
A similar observation was demonstrated also by Taiwan
authors [10]. They described a 59-year old hypertensive
diabetic female who during 6 years on HD developed
dialysis associated hypotension (in the range 80–100/50–
60 mmHg). Blood pressure increased to the range 120–
140/60–80 mmHg on day 1st post transplantation. In
other study Muscroft et al. [11] assessed the improvement
of BP after a successful kidney transplantation in eight pa-
tients with IDH. They were immune high-risk patients
with the presence of DSA (Donor Specific Antibodies)
and had previously used the appropriate desensitizing pro-
cedures. Only one of eight patients received a kidney from
a deceased donor, the others received a kidney from living
donors. It should be emphasized that only four patients of
this group had hypotension <100 mmHg between HD
sessions. The authors draw attention to the large percentage
of complications during the pre-transplant period (central
Fig. 2 Blood pressure values during hospitalization
Fig. 1 Pressing amines doses during hospitalization
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retinal vein thrombosis) and the treatment period (bleeding,
intestinal ischemia). One patient who received a kidney from
a deceased donor died from complications associated
with the occurrence of ischemic bowel disease. In these
patients, different pressor amines (including norepineph-
rine) were used before transplantation [11]. No one of de-
scribed patients with hypotension had previous bilateral
nephrectomy.
Conclusions
To summarize, we for the first time described beneficial
effect of kidney transplantation in severe hypotensive
patients after bilateral nephrectomy. At the moment
there are no adequate standards dealing with the quali-
fications and kidney transplantation in patients with
chronic IDH. A successful kidney transplantation ob-
served in our patient suggests careful valuation of all
potential candidates for kidney transplantation, includ-
ing patients with IDH. It is very important, especially
for the young patients, on short-term dialysis and free
of additional disease. The necessary condition, however,
is the extensive diagnosis before the kidney transplant-
ation. On the basis of this case, as a minimum, we suggest
testing the cardiovascular system in accordance with the
standards governing the qualifications and further endo-
crine studies (rhythm of cortisol, ACTH) and studies of
the autonomic nervous system based on the Ewing’s bat-
tery tests to exclude disorders of the autonomic nervous
system. In the case of disorders of this system, it can be
expected that the patient would not respond to treatment
with dopamine. The use of vasoconstrictive drugs, such as
phenylephrine, or high doses of norepinephrine may be
associated with an increased incidence of fatal complica-
tions in this group of patients.
Abbreviation
ACTH: Adrenocorticotropic hormone; BMI: Body mass index; BP: Blood pressure;
CKD: Chronic kidney disease; CT: Computed tomography; DBP: Diastolic blood
pressure; DSA: Donor specific antibodies; eGFR: Estimated glomerular filtration rate;
GS: Glicocorticosteroids; HD: Hemodialysis; HLA: Human leukocytes antigen;
IDH: Intradialytic hypotension; KDOQI: the National Kidney Foundation’s Kidney
Disease Outcomes Quality Initiative; MMF: Mycophenolate-mofetil; PRA: Panel
reactive antibody; SBP: Systolic blood pressure; TAC: Tacrolimus.
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